Pfizer garners positive momentum - Analysis - 20-07-2018

Pfizer's stock (PFE) fell in the intraday levels, as the stock gathers momentum to help it rise anew and vent off overbought saturation in the RSI, recording a loss of 0.80% in the last session, or 0.30 points, amid the dominance of the main upward trend in the medium and short terms, with positive pressure from the 50-day SMA. 

Therefore we expect the stock to return higher, targeting the pivotal resistance of 39.43, as long as it settles above 37.30.